George M. Milne Jr., Director at Amylyx Pharmaceuticals, Inc. (AMLX), bought 200,000 shares at $2.20 ($440K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Open-market purchase of $440k AMLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 100,000 | $220K | 50.0% |
| 2 | $2.20 | 100,000 | $220K | 50.0% |
| Total | $2.20 avg | 200,000 | $440K | 100% |
| Filing → |
| AUPH | BUY | 2022-03-08 | $54K | — | Filing → |
| AMLX | BUY | 2022-01-10 | $500K | — | Filing → |
| AUPH | BUY | 2021-03-09 | $65K | — | Filing → |